Livstruende menstruationsblødning efter opstart af rivaroxaban

Luna Fabricius Ekenberg; Line Markdanner Lindgren; Caroline Pehrson

doi:10.61409/V01240012

Livstruende menstruationsblødning efter opstart af rivaroxaban

Luna Fabricius Ekenberg, Line Markdanner Lindgren, Caroline Pehrson^*

^*Corresponding author af dette arbejde

Gynækologisk/Obstetrisk Afdeling

Publikation: Bidrag til tidsskrift › Artikel › Forskning › peer review

Abstract

This is a case report of a 44-year-old premenopausal woman who was admitted to hospital due to uncontrollable and life-threatening vaginal bleeding after starting rivaroxaban treatment for atrial fibrillation. She had a medical history with menorrhagia due to an intrauterine fibroma. She did not respond sufficiently to factor X supplement or other non-surgical medical interventions. The bleeding subsided after bilateral embolization of aa. uterinae.

Bidragets oversatte titel	Life-threatening vaginal bleeding after starting rivaroxaban treatment
Originalsprog	Dansk
Artikelnummer	V01240012
Sider (fra-til)	1710-1711
Antal sider	2
Tidsskrift	Ugeskrift for laeger
Vol/bind	186
Udgave nummer	18
Tidlig onlinedato	27 maj 2024
DOI	https://doi.org/10.61409/V01240012
Status	Udgivet - 16 sep. 2024

Emneord

Humans
Rivaroxaban/adverse effects
Female
Adult
Factor Xa Inhibitors/adverse effects
Uterine Hemorrhage/chemically induced
Atrial Fibrillation/drug therapy
Leiomyoma/drug therapy
Menorrhagia/chemically induced
Uterine Neoplasms/drug therapy

Adgang til dokumentet

10.61409/V01240012

Citationsformater

@article{4e4b879c13b9463e8ac02fd3248f25cf,

title = "Livstruende menstruationsbl{\o}dning efter opstart af rivaroxaban",

abstract = "This is a case report of a 44-year-old premenopausal woman who was admitted to hospital due to uncontrollable and life-threatening vaginal bleeding after starting rivaroxaban treatment for atrial fibrillation. She had a medical history with menorrhagia due to an intrauterine fibroma. She did not respond sufficiently to factor X supplement or other non-surgical medical interventions. The bleeding subsided after bilateral embolization of aa. uterinae.",

keywords = "Humans, Rivaroxaban/adverse effects, Female, Adult, Factor Xa Inhibitors/adverse effects, Uterine Hemorrhage/chemically induced, Atrial Fibrillation/drug therapy, Leiomyoma/drug therapy, Menorrhagia/chemically induced, Uterine Neoplasms/drug therapy",

author = "Ekenberg, {Luna Fabricius} and Lindgren, {Line Markdanner} and Caroline Pehrson",

note = "Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.",

year = "2024",

month = sep,

day = "16",

doi = "10.61409/V01240012",

language = "Dansk",

volume = "186",

pages = "1710--1711",

journal = "Ugeskrift for laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "18",

}

TY - JOUR

T1 - Livstruende menstruationsblødning efter opstart af rivaroxaban

AU - Ekenberg, Luna Fabricius

AU - Lindgren, Line Markdanner

AU - Pehrson, Caroline

N1 - Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

PY - 2024/9/16

Y1 - 2024/9/16

N2 - This is a case report of a 44-year-old premenopausal woman who was admitted to hospital due to uncontrollable and life-threatening vaginal bleeding after starting rivaroxaban treatment for atrial fibrillation. She had a medical history with menorrhagia due to an intrauterine fibroma. She did not respond sufficiently to factor X supplement or other non-surgical medical interventions. The bleeding subsided after bilateral embolization of aa. uterinae.

AB - This is a case report of a 44-year-old premenopausal woman who was admitted to hospital due to uncontrollable and life-threatening vaginal bleeding after starting rivaroxaban treatment for atrial fibrillation. She had a medical history with menorrhagia due to an intrauterine fibroma. She did not respond sufficiently to factor X supplement or other non-surgical medical interventions. The bleeding subsided after bilateral embolization of aa. uterinae.

KW - Humans

KW - Rivaroxaban/adverse effects

KW - Female

KW - Adult

KW - Factor Xa Inhibitors/adverse effects

KW - Uterine Hemorrhage/chemically induced

KW - Atrial Fibrillation/drug therapy

KW - Leiomyoma/drug therapy

KW - Menorrhagia/chemically induced

KW - Uterine Neoplasms/drug therapy

U2 - 10.61409/V01240012

DO - 10.61409/V01240012

M3 - Artikel

C2 - 38847299

SN - 0041-5782

VL - 186

SP - 1710

EP - 1711

JO - Ugeskrift for laeger

JF - Ugeskrift for laeger

IS - 18

M1 - V01240012

ER -

Livstruende menstruationsblødning efter opstart af rivaroxaban

Abstract

Emneord

Adgang til dokumentet

Fingeraftryk

Citationsformater